Xylem (XYL) Tops Q3 EPS by 10c; offers guidance

Xylem (NYSE: XYL) reported Q3 EPS of $0.99, $0.10 better than the analyst estimate of $0.89. Revenue for the quarter came in at $2.1 billion versus the consensus estimate of $1.99 billion.

GUIDANCE:

Xylem sees FY2023 EPS of $3.71-$3.73, versus the consensus of $3.62. Xylem sees FY2023 revenue of $7.3 billion, versus the consensus of $7.201 billion.

For earnings history and earnings-related data on Xylem (XYL) click here.

You May Also Be Interested In

• CAE, Inc. (CAE) Tops Q1 EPS by 2c, Beats on Revenue; Offers FY27 EPS Guidance
• MariMed Inc. (MRMD) Reports In-Line Q2 EPS
• Forward Industries, Inc. (FWDI) Misses Q2 EPS by 83c